JFL Life Sciences Limited (NSE:JFLLIFE)

India flag India · Delayed Price · Currency is INR
12.00
+0.55 (4.80%)
At close: Feb 10, 2026
Market Cap395.94M -40.2%
Revenue (ttm)744.78M -1.2%
Net Income35.17M -34.4%
EPS0.80 -50.7%
Shares Out33.00M
PE Ratio14.98
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,000
Average Volume25,500
Open11.95
Previous Close11.45
Day's Range11.95 - 12.00
52-Week Range10.00 - 22.35
Beta-0.69
RSI56.95
Earnings DateJan 29, 2026

About JFL Life Sciences

JFL Life Sciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers beta lactam dry powder injections, beta lactam tablets and capsules in solid oral dosage form, oral rehydration solutions, and general tablets and capsules. It also exports its products to Africa, the Middle East, and CIS countries through merchant exporters. JFL Life Sciences Limited was incorporated in 2010 and is headquartered in Ahmedabad, India. [Read more]

Industry Pharmaceutical Preparations
Founded 2010
Country India
Stock Exchange National Stock Exchange of India
Ticker Symbol JFLLIFE
Full Company Profile

Financial Performance

In fiscal year 2025, JFL Life Sciences's revenue was 820.42 million, an increase of 74.49% compared to the previous year's 470.19 million. Earnings were 41.59 million, an increase of 26.00%.

Financial Statements